October 1, 2020 Print
Around 120,000 Australians have type 1 diabetes. They require insulin by injection several times a day, but even then, long-term complications can include kidney and heart disease, vision loss and nerve damage.
Professor Philip O'Connell, Executive Director of The Westmead Institute for Medical Research (WIMR), is internationally recognised as a pioneer in the field of islet transplantation, having delivered Australia's first clinical trial after more than a decade of research.
In theory, islet transplantation involves taking healthy islet cells from a donor and transplanting them into a recipient's pancreas. In practice, it gives hope to patients with type 1 diabetes.
Interested in learning more about islet transplantation as a treatment for type 1 diabetes? Join Professor O'Connell, his colleague Associate Professor Natasha Rogers, and Professor Thomas Kay from St Vincent's Institute of Medical Research, as well as islet transplant recipients, as they discuss islet transplantation, the clinical trials underway in Australia, and the impact the transplant can have on recipients' lives.
Islet Transplantation - A New Treatment for Type 1 Diabetes is an interactive online panel discussion hosted by WIMR and the JDRF, with the support of the Australian Islet Transplantation Consortium. It will be followed by a Q&A with the panel.
This event is free to attend, but registration is essential. Click here to register.